Results for tag: "Chronic Total Occlusion System"

The Chronic Total Occlusion (CTO) System is a type of cardiovascular device used to treat coronary artery disease. It is designed to open blocked arteries and restore blood flow to the heart. The CTO System consists of a catheter, guidewire, and other tools used to cross the occlusion and restore blood flow. The CTO System market is driven by the increasing prevalence of coronary artery disease, technological advancements, and the growing demand for minimally invasive treatments. The CTO System market is segmented by product type, application, end user, and geography. The product type segment includes guidewires, catheters, balloons, and other accessories. The application segment includes percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG). The end user segment includes hospitals, ambulatory surgical centers, and other healthcare facilities. Some of the major companies in the CTO System market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, and B. Braun Melsungen AG. Show Less Read more